Detection of hepatitis C (HCV) NS5A and NS3 drug resistance associated mutations (RAMs) and polymorphisms by deep sequencing in subjects from BMS AI452008 Part A (the D-LITE Study)

被引：0
|
作者：
Kozal, M. J. [1 ,2 ]
Chiarella, J. [1 ,2 ]
Lee, C. C. [3 ]
Parikh, C. [3 ]
Teefe, E. [3 ]
Kyriakides, T. [1 ,2 ]
Harkins, T. T. [3 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Vet Affairs Healthcare Syst, New Haven, CT USA
[3] Thermo Fisher Sci, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
20
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 16 条
  • [1] Baseline drug resistance mutations are detectable by population sequencing in hepatitis C genes NS3 and NS5A but not NS5B in acute and chronic hepatitis C/HIV co-infected patients
    McCormick, A.
    Moynihan, L.
    Macartney, M.
    Garcia-Diaz, A.
    Conibear, T.
    Booth, C.
    Bhagani, S.
    Rodger, A.
    Johnson, M.
    Haque, T.
    Webster, D.
    HIV MEDICINE, 2014, 15 : 138 - 138
  • [2] Occurrence of polymorphisms and resistant mutations in the NS3, NS5A and NS5B genes of HCV based on sequences deposited in the European Hepatitis C Virus Database (euHCVdb).
    Kliemann, Dimas A.
    Tovo, Cristiane V.
    Gorini da Veiga, Ana B.
    Machado da Silval, Andre L.
    Wood, Charles
    de Mattos, Angelo Alves
    HEPATOLOGY, 2016, 64 : 747A - 748A
  • [3] Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing
    Bergfors, Assar
    Leenheer, Daniel
    Bergqvist, Anders
    Ameur, Adam
    Lennerstrand, Johan
    ANTIVIRAL RESEARCH, 2016, 126 : 81 - 89
  • [4] Drug resistance mutations in the HCV NS3 protease and NS5B polymerase in newly diagnosed HIV-1 patients with chronic hepatitis C in Spain
    Trevino, A.
    de Mendoza, C.
    Parra, P.
    Rodriguez, C.
    Madejon, A.
    Plaza, Z.
    del Romero, J.
    Poveda, E.
    Soriana, V.
    ANTIVIRAL THERAPY, 2010, 15 : A115 - A115
  • [5] Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine
    Ikram, Aqsa
    Obaid, Ayesha
    Awan, Faryal Mehwish
    Hanif, Rumeza
    Naz, Anam
    Paracha, Rehan Zafar
    Ali, Amjad
    Janjua, Hussnain Ahmed
    ANTIVIRAL RESEARCH, 2017, 137 : 112 - 124
  • [6] Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naive patients with chronic hepatitis C
    Costantino, Angela
    Spada, Enea
    Equestre, Michele
    Bruni, Roberto
    Tritarelli, Elena
    Coppola, Nicola
    Sagnelli, Caterina
    Sagnelli, Evangelista
    Ciccaglione, Anna Rita
    VIROLOGY JOURNAL, 2015, 12
  • [7] Natural resistance associated polymorphisms are detectable at baseline in direct acting antiviral (DAA) naive hepatitis C NS3 and NS5A but not NS5B in acute and chronic HIV co-infected patients
    McCormick, A. L.
    Moynihan, L.
    Macartney, M.
    Garcia-Diaz, A.
    Conibear, T.
    Booth, C.
    Bhagani, S.
    Rodger, A.
    Johnson, M. A.
    Haque, T.
    Webster, D. P.
    ANTIVIRAL THERAPY, 2014, 19 : A113 - A113
  • [8] Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
    Angela Costantino
    Enea Spada
    Michele Equestre
    Roberto Bruni
    Elena Tritarelli
    Nicola Coppola
    Caterina Sagnelli
    Evangelista Sagnelli
    Anna Rita Ciccaglione
    Virology Journal, 12
  • [9] Analysis by population-and deep-sequencing of polymorphisms with excessive resistance to NS5A inhibitors in treatment-naive subjects with HCV genotype 1a and 3a
    Leenheer, D.
    Lindstrom, I.
    Ameur, A.
    Kjellin, M.
    Wesslen, L.
    Lannergard, A.
    Lennerstrand, J.
    ANTIVIRAL THERAPY, 2014, 19 : A109 - A109
  • [10] NS3 protease polymorphisms and genetic barrier to drug resistance of distinct hepatitis C virus genotypes from worldwide treatment-naive subjects
    Vidal, L. L.
    Soares, M. A.
    Santos, A. F.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (11) : 840 - 849
12